CASE 16670 Published on 02.04.2020

CT appearance of two cases of novel coronavirus pneumonia (COVID-19)


Chest imaging

Case Type

Clinical Cases


Michele Di Martino Ph.D.¹ ²; Andrea Porfiri, MD²; Giulia Anello, MD²; Luigi Corinto, MD²

1. Department of Radiological Sciences, Oncology and Anatomical Pathology, University of Rome “Sapienza”, Viale Regina Elena 324, Rome, 00161, Italy. -
2. Medicenter Group  S.r.l. Via Salaria 187, Monterotondo (RM), 00015



63 years, male

Area of Interest Lung ; Imaging Technique CT
Clinical History

We report a private practice experience of two cases of novel coronavirus pneumonia (COVID-19) patients who were referred at our attention due to the persistence of a-specific symptoms.

Case 1
A 63-year-old man affected by hypertension performed X-ray examination for dispnoea: he had history of two-days-fever (37.5° C) one week before.
Patient did not perform chemistry analysis before imaging examinations.
X-ray exam did not show any abnormalities; but after 2 days he underwent high-resolution computed tomography (HRCT) examination as a further study.

Case 2
A 80-year-old woman with asthenia, fever and mental confusion, recommended by her doctor, performed X-ray of the chest. The exam showed an opacity in the right lobe, therefore HRCT diagnostic deepening was suggested. The patient reported that in the last two weeks she only met her children and did not perform chemistry analysis before.

Imaging Findings

Non-enhanced CT exams were acquired with a Multislice-Computed Tomography
scanner (GE Optima 64, General Electric Healthcare, Milwaukee, WI) with the
following parameters: kV 120, mAs 80-300, rotation time 0.5 sec, slice thickness
1.25 mm.
HRCT image of case 1 showed a rare diffuse ground-glass opacitity (GGO) with interlobular septal thickening in the subpleural area of the postero-inferior segments of both lobes with a more accentuated finding on the right (Fig. 1).
HRCT image of case 2 reported different pattern with bilateral multifocal
GGOs associated with consolidation areas with patchy distribution,
predominantly peripheral/subpleuric and with greater involvement of the middle
and lower lobes (Fig. 2).


The new coronavirus, SARS-CoV-2 (severe acute respiratory syndrome
coronavirus-2), is identified as causing lung infection, now called COVID-
19 (Coronavirus disease-2019). It was first reported in the city of Wuhan in
central China, but at present it has spread all over the world, therefore it has been
classified by the World Health Organization as pandemia. [1]
The infection tends to be asymptomatic or with aspecific symptoms (fever, cough,
asthenia, diarrhoea). However, in almost 10% of cases, generally with older people with comorbidity,
it could evolve into respiratory failure for diffuse alveolar damage
(acute respiratory distress syndrome), multi organ failure (MOF)
extrapolmonary and shock, up to the exitus [2-4].

At the early stage, X-ray examination should be normal; in the advanced stages X-ray
of the chest shows bilateral multifocal alveolar opacifications, which tend to
confluence until the lung is completely opaque, with possible small association of
pleural fluid. [5]
At HRCT, COVID-19 pneumonia has various and nonspecific findings and patterns,
that may be encountered in other lung infections, such as influenza A, CMV, other
coronaviruses (SARS, MERS), streptococcus and pneumonia from atypical germs
(clamydia, mycoplasma); however in literature different patterns of this
viral infection at different stages of the disease are described.
In the early stage, focal or diffuse GGOs are the most common finding as reported by different studies with an incidence ranging from 57 to 98% [6-8].
Advanced disease is characterised by multifocal and bilateral GGOs, ‘crazy paving’ pattern, reversed halo-sign until pulmonary consolidations.
‘Crazy paving’ pattern is sometimes present and according to the study of Pan et al. is associated with a progression from advanced to peak stage [9].
Reversed halo-sign was found in different cases of advanced disease and its considered a sign of progression [8]
Multifocal, patchy, or segmental consolidation, distributed in subpleural areas or along bronchovascular bundles, is usually presented and associated with progression of clinical symptoms.
Other signs described in literature are vascular enlargement nearby the lesions, focal nodules and fibrosis [10].
Lymph node enlargement is not often encountered in patients affected by COVID-19 pneumonia.
According to the study published by Pan et al. case 1 should be classified as early stage disease and the second one as progressive stage disease [9]. Patients were immediately informed of the risk of COVID-19 infection and directed to the first aid relevant facilities. The final diagnosis was made by real time – polymerase chain reaction (RT-PCR) obtained from oropharyngeal swab specimens.

Written patient consent for this case was waived by the Editorial Board. Patient data may have been modified to ensure patient anonymity.

Differential Diagnosis List
Coronavirus disease 2019 pneumonia (COVID-19)
Non-specific interstitial pneumonia
Mycoplasma pneumonia
Viral pneumonia
Bacterial pneumonia
Hypersensitivity pneumonitis (HSP)
Final Diagnosis
Coronavirus disease 2019 pneumonia (COVID-19)
Case information
DOI: 10.35100/eurorad/case.16670
ISSN: 1563-4086